• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number RONYX25026UX
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Unspecified Tissue Injury (4559)
Date of Event 03/11/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
During a procedure an attempt was made to use one resolute onyx rx coronary drug eluting stent to treat a lesion.The device was inspected with no issues noted.The lesion was pre-dilated.It was reported that stent dislodgement occurred during removal following a failed delivery.The dislodged stent was not removed.The dislodged stent was crushed against a vessel.The patient was reported to be alive with no further injury.
 
Additional Manufacturer Narrative
Device evaluation summary: delivery system returned for evaluation.The stent was not present on the balloon and did not return for analysis.The balloon folds remained intact.Crimp impressions were visible on the exposed balloon surface.The inner lumen patency was verified with a 0.015 inch mandrel.No other damage was noted to the remainder of the delivery system.Correction: the obtuse marginal 2 had an acute thrombotic occlusion which was ballooned.The obtuse marginal 1 had a previous stent.Two stents were used.The first stent was not able to pass the lesion after two attempts and therefore was not deployed.The second stent ronyx25026ux eventually came off the balloon.The device did not pass through the previously deployed stent.Resistance was noted when advancing the device in the lesion and excessive force was not used.The stent initially dislodged in the left main/left circumflex.The stent came off the balloon after two attempts of withdrawing the device.No resistance was noted during withdrawal of the device until the very end where balloon slipped off.Another balloon was used to crush the device.Patient age, weight, relevant history added.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
MDR Report Key11573983
Report Number9612164-2021-01179
Device Sequence Number4455681
Product Code NIQ
UDI-Device Identifier00643169556836
UDI-Public00643169556836
Combination Product (Y/N)N
Initial Reporter StateDE
Initial Reporter CountryUS
PMA/510(K) Number
P160043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/22/2022
Device Model NumberRONYX25026UX
Device Catalogue NumberRONYX25026UX
Device Lot Number0010424937
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/07/2021
Initial Date Received by Manufacturer 03/23/2021
Supplement Date Received by Manufacturer07/09/2021
Initial Report FDA Received Date03/26/2021
Supplement Report FDA Received Date07/13/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age48 YR
-
-